Sava Infond d.o.o. Makes New $3.26 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Sava Infond d.o.o. acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 6,450 shares of the healthcare conglomerate's stock, valued at approximately $3,263,000.

Other institutional investors also recently bought and sold shares of the company. M&T Bank Corp raised its position in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock valued at $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after acquiring an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. lifted its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock valued at $26,060,000 after purchasing an additional 41,308 shares during the period. Parsifal Capital Management LP acquired a new stake in UnitedHealth Group during the third quarter worth about $21,165,000. Finally, Signal Advisors Wealth LLC boosted its position in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after purchasing an additional 1,051 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.33% of the stock is owned by insiders.

Remove Ads

UnitedHealth Group Trading Down 0.0 %

NYSE UNH traded down $0.25 on Friday, reaching $515.47. 2,378,211 shares of the company were exchanged, compared to its average volume of 4,268,981. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business's fifty day moving average price is $508.81 and its 200 day moving average price is $544.24. The stock has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $5.83 earnings per share. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.

Analysts Set New Price Targets

Several research firms recently issued reports on UNH. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday, January 17th. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. Twenty investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of "Buy" and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.